Deck 8: Drugs Affecting the Autonomic Ganglia

Question 1

A patient complains of weakness,dizziness,and feelings of faintness when standing up.Using your knowledge of ganglionic stimulants and blockers,you determine from the patient's medication profile that the drug that is probably causing these adverse effects is:

A) Mecamylamine
B) Buproprion
C) Chantix
D) None of these are correct.

Answer 1

Mecamylamine

Question 2

Differentiating between the adverse effects of Nicorette and Nicoderm,you determine that use of Nicorette can result in all of the following adverse effects except:

A) Taste disturbances
B) Jaw soreness
C) Nausea
D) Nervousness

Answer 2

Nervousness

Question 3

Implementing a treatment plan that includes mecamylamine requires monitoring the patient for:

A) Respiratory difficulties
B) Depression of the cardiovascular system
C) Nervousness
D) Constipation

Answer 3

Depression of the cardiovascular system

Question 4

When selecting bupropion for treatment of smoking cessation,it is important to differentiate between bupropion and the nicotine replacement products.Bupropion:

A) Is an antidepressant
B) Has an adverse effect profile that includes insomnia, dry mouth, and GI disturbances
C) Is available as 25-, 50-, 75-, and 150-mg tablets
D) All of these are correct.

Question 5

Use of nicotine products leads to sympathetic stimulation.As a result,one can conclude that:

A) Heart rate will increase.
B) Blood pressure will decrease.
C) GI activity will decrease.
D) All of these are correct.

Question 6

Select the main effect of the ganglionic blockers on the gastrointestinal system.

A) Decrease blood pressure
B) Decrease intestinal secretions
C) Decrease urination
D) Decrease cardiac output

Question 7

Identify the neurotransmitter found at the autonomic ganglia that stimulates the nicotinic-neural (Nn) receptors.

A) Serotonin
B) Epinephrine
C) Acetylcholine
D) Dopamine

Question 8

Implementing a treatment plan that includes mecamylamine is indicative of a diagnosis of:

A) Smoking addiction
B) Severe hypertension
C) Depression
D) Constipation

Question 9

Implementing a treatment plan that includes ganglionic blocking drugs and vasodilators could lead to a drug interaction that could result in:

A) Additive anticholinergic effects
B) Additive vasodilating effects
C) Antagonism of anticholinergic effects
D) Additive antiadrenergic effects

Question 10

Nicorette gum has been classified as Pregnancy Category:

A) A
B) B
C) C
D) D

Question 11

Match the drug preparation verenicline with the correct trade name:

A) Zyban
B) Commit
C) Chantix
D) Wellbutrin SR

Question 12

When differentiating between ganglionic stimulants and ganglionic blockers,you determine that ganglionic stimulants:

A) Stop the craving for nicotine
B) Treat severe hypertension
C) Have little clinical use
D) None of these are correct.

Question 13

A patient's wife is concerned that her husband is overusing the Nicorette 4-mg gum product.She would like to confirm how many pieces he can use in a day.Using what you know about Nicorette gum,you determine that the dosage is limited to:

A) 20 pieces per day
B) 10 pieces per day
C) 30 pieces per day
D) None of these are correct.

Question 14

Selection of the ganglionic blockers for the treatment of severe hypertension in males can lead to:

A) Increased urination
B) Decreased intestinal secretions
C) Impotence
D) Increased bladder contractions

Question 15

Integrating a nicotine replacement product while the patient continues to indulge in smoking cigarettes could lead to:

A) Toxic doses of nicotine in the body
B) Ganglionic blockade
C) Decreased respiratory function
D) All of these are correct.

Question 16

What was the name used for the receptors at the autonomic ganglia prior to the discovery of the neurotransmitter acetylcholine?

A) Serotonin receptors
B) Nicotinic receptors
C) Epinephrine receptors
D) Dopamine receptors

Question 17

A patient who recently started on a smoking cessation treatment plan is complaining of throat irritation.Using what you have learned about the smoking cessation products,you determine that this adverse effect is due to his use of:

A) Nicorette
B) Nicotrol Inhaler
C) Chantix
D) Nicorette gum

Question 18

Integrating a cholinergic drug into the existing treatment plan of a patient already taking a ganglionic blocking drug could result in a drug interaction characterized by:

A) Additive anticholinergic effects
B) Additive vasodilating effects, leading to hypotension and cardiovascular collapse
C) Antagonism of anticholinergic effects, especially on the GI and urinary tracts
D) Additive antiadrenergic effects leading to hypotension and cardiovascular collapse

Question 19

When integrating a smoking cessation treatment with the Nicotrol inhaler,it should be used with caution because:

A) Use of the inhaler may cause nervousness.
B) Use of the inhaler may cause heartburn.
C) Use of the inhaler may cause minor breathing difficulties.
D) None of these are correct.

Question 20

Ganglionic blockers are contraindicated in patients with glaucoma.You interpret this to be due to the fact that:

A) The ganglionic blockers have a mydriatic effect that increases intraocular pressure.
B) The ganglionic blockers have a mydriatic effect that decreases intraocular fluid.
C) The ganglionic blockers have a miotic effect that increases intraocular pressure
D) None of these are correct